Non-Operative Management in Rectal Cancer Contemporary Practice
Modern treatment options such as radiotherapy dose intensification (EBRT boost, brachytherapy or Papillon technique) or additional chemotherapy in total neoadjuvant therapy for rectal cancers have been shown to improve rectal preservation rates better than ever before. Recently published studies provide level-one evidence, making these standard-of-care options more than an overt demand as in the past. Organ preservation directly impacts quality of life and care satisfaction in these patients. Radiation oncologists play a central and pivotal role in realizing organ preservation.
Topics:
- Overview
Rahul Krishnatry, MD - Contact Brachytherapy: Practical Considerations, Evidence and QOL
Alexandra Stewart, MRCP, FRCR, DM - High Dose Rate Endorectal Brachytherapy in the Non-Operative Management of Patients With Rectal Cancer
Té Vuong, MD, FRCP - HDR Brachytherapy, MRI Based: How We Do It & Evidence
Reena Engineer, MBBS, DMRT, MD, DNB - Total Neoadjuvant Therapy and Non-Operative Management
Smitha Krishnamurthi, MD
This activity is available from October 1, 2024, through 11:59 p.m. Eastern time on September 30, 2026.
Target Audience
The activity is designed to meet the interests of radiation oncologists, medical oncologists, surgeons, radiation physicists, and residents.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Determine suitable rectal cancer patients for organ preservation and apply new strategies for achieving it such as radiotherapy dose escalation and total neoadjuvant therapy.
- Discuss the impact of organ preservation on patient outcomes and care provider satisfaction.
- Rahul Krishnatry, MD, is employed by Tata Memorial Centre. Dr. Krishnatry serves as Secretary on the Executive Committee for the Gastrointestinal Oncology Society.
- Alexandra Stewart, MRCP, FRCR, DM, is employed by Royal Surrey County Hospital. Dr. Stewart receives compensation/pay as a medical advisor for TRUEinvivo and is minority shareholder in TRUEinvivo, Dr. Morton's, and Mount Alvernia PET CT Ltd. Dr. Stewart is Chair of the GEC-ESTRO gastrointestinal working group.
- Té Vuong, MD, FRCP, is employed by Jewish General Hospital.
- Reena Engineer, MBBS, DMRT, MD, DNB, is employed by Tata Memorial Centre.
- Smitha Krishnamurthi, MD, is employed by the Cleveland Clinic. Dr. Krishnamurthi’s institution receives grant/research funding from Agenus and BioMed Valley.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.25 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
Nonmember: $149
Member: $99
Member-in-training: $49
Student/Grad Student/PGY Member: $49
Postdoctoral Fellow Member: $49
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website until September 30, 2026, regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.